期刊文献+

透骨草提取物对人肝癌SMMC-7721细胞p53和PUMA蛋白表达的影响

Effects of Phryma Leptostachya L. var. asiatica Hara Extract on Expressions of p53 and PUMA Proteins in Human Hepatocellular Carcinoma SMMC- 7721 Cells
下载PDF
导出
摘要 目的观察透骨草提取物对人肝癌SMMC-7721细胞形态和p53和p53上调凋亡调控因子(PUMA)蛋白表达的影响,探讨透骨草提取物诱导SMMC-7721细胞凋亡的分子机制。方法用倒置显微镜观察透骨草提取物对SMMC-7721细胞形态的影响;采用免疫组化方法检测透骨草提取物对SMMC-7721细胞p53和PUMA蛋白表达的影响。结果倒置显微镜观察可见,40.91μg/mL透骨草提取物处理的SMMC-7721细胞体积减小,形态轮廓不清晰,细胞皱缩变形,细胞脱壁增加。免疫组化检测结果显示,40.91μg/mL透骨草提取物处理的SMMC-7721细胞p53蛋白和PUMA蛋白表达均明显高于与对照组(P<0.01)。结论透骨草提取物可能通过上调p53和PUMA蛋白表达,诱导SMMC-7721细胞凋亡。 :Objectlve To observe the effects of Phryma leptostachya L. vat. asiatica Hara extract on the morphology and the expressions of p53 and PUMA proteins in human hepatocellular carcinoma SMMC-7721 cells,in order to investigate the molecular mechanism for Phryma leptostachya L. var. asiatica Hara extract inducing SMMC-7721 cell apoptosis. Methods The morphology of SMMC-7721 cells was observed with the inverted microscope. Immunohistochemistry technique was used to determine the expressions of p53 and PUMA proteins of SMMC-7721 cells. Results After SMMC- 7721 cells were treated with 40. 91 μg/mL Phryma leptostachya L. var. asiatica Hara extract, the changes of the volume of SMMC-7721 cell reduced, morphological profile became unclear, cell shrinkage was de- formed, and the number of exfoliative cells increased were observed with inverted microscope. Immunohistochemistry technique showed that the expressions of p53 and PUMA proteins of SMMC-7721 cells treated with 40.91 μg/mL Phryma Leptostachya L. var. asiatica Hara Extract increased than control group (P 〈 0. 01). Conclusion Phryma Leptostachya L. var. asiatica Hara Extract could induce the apoptosis of SMMC- 7721 cells by upregulating the expressions of p53 and PUMA proteins.
出处 《中国药业》 CAS 2013年第20期19-20,共2页 China Pharmaceuticals
基金 2010年大连市科学技术基金计划项目 项目编号:2010E13SF144
关键词 透骨草提取物 SMMC-7721细胞 凋亡 P53 p53上调凋亡调控因子 Phryma Leptostachya L. var. asiatica Hara extract SMMC - 7721 cells apoptosis p53 PUMA
  • 相关文献

参考文献4

二级参考文献41

  • 1江中勇,杨凌,陈清勇.Fas/FasL与肺癌关系的研究进展[J].国外医学(呼吸系统分册),2005,25(2):115-117. 被引量:4
  • 2陈光,丁晓飞,肖晋芳,韩重,王敏伟,徐丽英,董金华.榄香烯衍生物诱导HeLa细胞凋亡的实验研究[J].中国药理学通报,2007,23(2):246-250. 被引量:11
  • 3Baselga J,Mendelsohn J.The epidermal growth factor receptor as a target for therapy in breast carcinoma.Breast Cancer Res Treat 1994; 29:127-138.
  • 4Bange J,Zwick E,Ullrich A.Molecular targets for breast cancer therapy and prevention.Nat Med 2001; 7:548-552.
  • 5Chopin V,ToiUon RA,Jouy N,Le Bourtfis X.p21 (WAF1/CIP1) is dispensable for GI arrest,but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells.Oncogene 2004; 23:21-29.
  • 6Nelson K.3-bromopyruvate kills cancer cells in animals.Lancet Oncol 2002; 3:524-524.
  • 7Geschwind JF,Ko YH,Torbenson MS,Magee C,Pedersen PL.Novel therapy for liver cancer:direct intraarterial injection of a potent inhibitor of ATP production.Cancer Res 2002; 62:3909-3913.
  • 8Pedersen PL.The cancer cell's "power plants" as promising therapeutic targets:an overview.J Bioenerg Biomembr 2007; 39:1-12.
  • 9Ko YH,Pedersen PL,Geschwind JF.Glucose catabolism in the rabbit VX2 tumor model for liver cancer:characterization and targeting hexokinase.Cancer Lett 2001; 173:83-91
  • 10Foublster V,Writer E Energy blocker to treat liver cancer.Drug Discov Today 2002; 7:934-935

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部